The Regina Elena National Cancer Institute (IFO-IRE)
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pace, Andrea
ACTION, NCT05580562: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the Study)

Calendar Jan 2026 - Dec 2026: Final data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma
Calendar Jan 2025 - Mar 2025: Interim data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma
Recruiting
3
450
Europe, Canada, Japan, US, RoW
Dordaviprone (ONC201), Dordaviprone (ONC201) + Placebo, Placebo
Chimerix
H3 K27M, Glioma
08/26
08/26
RACTAC, NCT04224441: Repurposing Chlorpromazine in the Treatment of Glioblastoma

Recruiting
2
41
Europe
Chlorpromazine Pill, Temozolomide
Marco G Paggi, MD, PhD, Regina Elena Cancer Institute, Carlo Besta Neurological Institute, Istituto Oncologico Veneto IRCCS
Glioblastoma Multiforme, MGMT-Unmethylated Glioblastoma
06/22
12/22
NCT04762069 / 2021-003659-40: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Hourglass Jan 2023 - Jun 2023 : Data from trial for glioblastoma
Hourglass Jul 2022 - Dec 2022 : Interim analysis data from trial for glioblastoma in adults
Active, not recruiting
2
210
Europe, US
Berubicin, Berubicin Hydrochloride, Lomustine, Lomustine Capsules, CCNU, CeeNU, Gleostine
CNS Pharmaceuticals, Inc., Worldwide Clinical Trials
Glioblastoma Multiforme, Adult
12/24
03/25
eCAN, NCT06007001: Telerehabilitation and Tele-psychological Support in Cancer Patients JA

Recruiting
N/A
354
Europe, RoW
Telemedicine
Sciensano, European Commission
Cancer
09/24
09/24
SILMET, NCT05689619: SILibinin in NSCLC and BC Patients With Single Brain METastasis

Recruiting
N/A
70
Europe
Silibinin, Sillbrain, Placebo
Azienda Ospedaliera Città della Salute e della Scienza di Torino
Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer
09/25
09/27

Download Options